肠道穿孔是博尔特佐米布诱导的自主神经病变的次要原因
Jose Antonio Sánchez Salas1, Maria Jose Moreno Belmonte1, Andrea Poveda García1
1Department of Hematology Virgen de la Arrixaca University Hospital Murcia Spain.
Clinical case reports
|April 2, 2025
概括
在管理Bortezomib (BTZ) 毒性时,请考虑患者的病史和当前症状. 永久停止BTZ患者的3级肠道神经病变和穿孔的危险因素.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 博特佐米布 (Bortezomib,简称BTZ) 是一种蛋白酶体抑制剂,用于治疗多发性骨髓瘤和地幔细胞淋巴瘤.
- 管理BTZ诱导的毒性,特别是神经毒性,对于患者的安全和治疗坚持至关重要.
- 肠道神经病变是一个重大问题,可能导致严重的并发症.
研究的目的:
- 评估影响关于博特佐米布 (BTZ) 毒性管理决策的关键因素.
- 确定在发生严重不良事件的患者中永久停止BTZ治疗的标准.
主要方法:
- 来自临床试验的患者数据的回顾性分析 (NCT03710603).
- 评估患者先前的病情和临床表现的严重程度.
- 评估肠道神经病症等级和肠道穿孔风险因素的存在.
主要成果:
- 患者的先前病情和当前临床表现的严重程度是BTZ毒性管理的关键.
- 3级肠道神经病变,特别是具有结构异常或穿孔风险因素,需要永久停用BTZ.
结论:
- 仔细评估患者特异性因素对于安全有效的Bortezomib (BTZ) 治疗至关重要.
- 在患有严重肠道神经病变和相关风险的患者中,应强烈考虑永久停止BTZ治疗.
相关概念视频
Esophageal Perforation-I: Introduction
52
Esophageal perforation is a severe medical condition characterized by a breach in the integrity of the esophageal wall. This breach can occur due to various factors such as trauma, medical procedures, or underlying diseases. When the esophageal wall is compromised, it allows food, fluids, and digestive juices into the chest cavity or adjacent structures, leading to potential complications and health risks.
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
The location of esophageal perforation can vary, occurring anywhere along the esophagus....
52
Esophageal Perforation-II: Clinical Manifestations and Management
28
Esophageal perforations manifest in various clinical forms, influenced by factors such as the perforation's cause and location (cervical, intrathoracic, or intra-abdominal), the extent of contamination, and potential injury to adjacent mediastinal structures. The timing between the perforation occurrence and treatment initiation also affects the clinical presentation.
Clinical Manifestations:
Clinical Manifestations:
28
Inflammatory Bowel Disease I: Ulcerative Colitis
99
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
99
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
144
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
144
Peptic Ulcer Disease V: Surgical Management and Nursing Care
172
Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Surgical Interventions for Peptic Ulcer Disease
172
Inflammatory Bowel Disease II: Crohn's Disease
134
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
134


